Preclinical memory markers of Alzheimer's disease

被引：0
|
作者：
Rogers, S. A.
Miller, K. J.
Dejong, J.
Ercoli, L.
Siddarth, P.
Small, G.
机构：
来源：
CLINICAL NEUROPSYCHOLOGIST | 2006年 / 20卷 / 03期
关键词：
D O I：
暂无
中图分类号：
B849 [应用心理学];
学科分类号：
040203 ;
摘要：
引用
下载
收藏
页码：598 / 599
页数：2
相关论文
共 50 条
  • [31] Effect of amyloid on memory and non-memory decline from preclinical to clinical Alzheimer's disease
    Lim, Yen Ying
    Maruff, Paul
    Pietrzak, Robert H.
    Ames, David
    Ellis, Kathryn A.
    Harrington, Karra
    Lautenschlager, Nicola T.
    Szoeke, Cassandra
    Martins, Ralph N.
    Masters, Colin L.
    Villemagne, Victor L.
    Rowe, Christopher C.
    BRAIN, 2014, 137 : 221 - 231
  • [32] Deficits in Episodic Memory of Olfactory Percepts as a Potential Biomarker for Preclinical Alzheimer's Disease
    Albers, Mark
    Yan, Sandra
    Kelly, Kathleen
    Albers, Alefiya
    NEUROLOGY, 2013, 80
  • [33] Impairment of memory generalization in preclinical autosomal dominant Alzheimer's disease mutation carriers
    Petok, Jessica R.
    Myers, Catherine E.
    Pa, Judy
    Hobel, Zachary
    Wharton, David M.
    Medina, Luis D.
    Casado, Maria
    Coppola, Giovanni
    Gluck, Mark A.
    Ringman, John M.
    NEUROBIOLOGY OF AGING, 2018, 65 : 149 - 157
  • [34] Canaries in a coal mine -: Cognitive markers of preclinical Alzheimer disease
    Small, BJ
    Fratiglioni, L
    Bäckman, L
    ARCHIVES OF GENERAL PSYCHIATRY, 2001, 58 (09) : 859 - 860
  • [35] Neurofilament Light Predicts Decline in Attention but Not Episodic Memory in Preclinical Alzheimer's Disease
    Aschenbrenner, Andrew J.
    Gordon, Brian A.
    Fagan, Anne M.
    Schindler, Suzanne E.
    Balota, David A.
    Morris, John C.
    Hassenstab, Jason J.
    JOURNAL OF ALZHEIMERS DISEASE, 2020, 74 (04) : 1119 - 1129
  • [36] Correlations between cognitive, memory and peripheral signalling markers in Alzheimer's disease
    Hugon, Jacques
    NEUROBIOLOGY OF AGING, 2008, 29 : S12 - S13
  • [37] Associations between Metamemory and Markers of Brain Pathology in Preclinical Autosomal Dominant Alzheimer's Disease
    Chaudhry, T.
    Vannini, P.
    Norton, D. J.
    Guzman-Velez, E.
    Baena, A.
    Lopera, F.
    Sperling, R.
    Quiroz, Y. T.
    CLINICAL NEUROPSYCHOLOGIST, 2017, 31 (04) : 715 - 715
  • [38] APOE ε4 alters associations between docosahexaenoic acid and preclinical markers of Alzheimer's disease
    Coughlan, Gillian
    Larsen, Ryan
    Kim, Min
    White, David
    Gillings, Rachel
    Irvine, Michael
    Scholey, Andrew
    Cohen, Neal
    Legido-Quigley, Cristina
    Hornberger, Michael
    Minihane, Anne-Marie
    BRAIN COMMUNICATIONS, 2021, 3 (02)
  • [39] Changes in Synaptic Proteins Precede Neurodegeneration Markers in Preclinical Alzheimer's Disease Cerebrospinal Fluid
    Lleo, Alberto
    Nunez-Llaves, Raul
    Alcolea, Daniel
    Chiva, Cristina
    Balateu-Panos, Daniel
    Colom-Cadena, Marti
    Gomez-Giro, Gemma
    Munoz, Laia
    Querol-Vilaseca, Marta
    Pegueroles, Jordi
    Rami, Lorena
    Llado, Albert
    Molinuevo, Jose L.
    Tainta, Mikel
    Clarimon, Jordi
    Spires-Jones, Tara
    Blesa, Rafael
    Fortea, Juan
    Martinez-Lage, Pablo
    Sanchez-Valle, Raquel
    Sabido, Eduard
    Bayes, Alex
    Belbin, Olivia
    MOLECULAR & CELLULAR PROTEOMICS, 2019, 18 (03) : 546 - 560
  • [40] Sensitivity of a Preclinical Alzheimer's Cognitive Composite (PACC) to amyloid β load in preclinical Alzheimer's disease
    Bransby, Lisa
    Lim, Yen Ying
    Ames, David
    Fowler, Christopher
    Roberston, Joanne
    Harrington, Karra
    Snyder, Peter J.
    Villemagne, Victor L.
    Salvado, Olivier
    Masters, Colin L.
    Maruff, Paul
    JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY, 2019, : 591 - 600
12345